Your research can change the world
More on impact ›
The 'Translational Virology' section of Frontiers in Virology publishes high-class scientific articles and reviews. The challenge of Translational Virology is to cover all aspects from bench to bedside in taking a more holistic approach instead of including elements of biology systems at the same time paying attention to the details without losing to the understanding of the global picture. Therefore, topics cover a broad spectrum of areas in basic research on viruses such as bioinformatics, genetics, genomics, proteomics, and molecular biology, but keeping in mind that the ultimate goal is to develop safer and more efficient antiviral drugs and vaccines for clinical applications.
• Basic molecular biology of viruses
• Genetics and genomics on viruses
• Genetic and genomics on host organisms related to viral infections
• Genetic manipulations of viruses
• Antiviral drug and vaccine development
• Drug and vaccine development and production
• Clinical virology
• Viral epidemics and pandemics
The contributions to Translational Virology must provide new insights into how basic research can provide a better understanding of viruses in the context of the development of antiviral drugs and vaccines. Translation Virology supports any approach that can contribute to the discovery of new agents and technologies for the prevention and treatment of viral infections. Manuscripts improving and shortening the processes involved in antiviral drug and vaccine development are also welcome. The mission of Translational Virology is to improve any aspect related to accelerating and optimizing the transition from bench to bedside.
Indexed in: CLOCKSS, CrossRef, DOAJ, Google Scholar, OpenAIRE
Translational Virology welcomes submissions of the following article types: Brief Research Report, Case Report, Classification, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Translational Virology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com